United States· US:72789-457_48d8a76e-8103-9485-e063-6294a90af9ab
CEVIMELINE HYDROCHLORIDE
A cevimeline product containing cevimeline hydrochloride, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cevimeline is registered in 3 of 19 countries.
Countries holding a registration under ATC N07AX03 (cevimeline), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Cevimeline · ATC N07AX03
3 / 19 countries
- Japan
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEVIMELINE HYDROCHLORIDE
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- N07AX03
- ATC class
- Cevimeline
- Defined daily dose
- 90 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 23, 2026
Packs & prices · 4
- ndc1172789-457-01
- ndc1172789-457-30
- ndc117278945701100 CAPSULE in 1 BOTTLE, PLASTIC (72789-457-01)
- ndc11727894573030 CAPSULE in 1 BOTTLE, PLASTIC (72789-457-30)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
144 interactions on record for cevimeline.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cevimeline · interactions on record
144 records
- 2 severe
- 119 moderate
- 23 minor
Most severe, free to view
- SiponimodL04AA42severe
- SiponimodL04AE03severe
- ClotrimazoleA01AB18moderate
- CimetidineA02BA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cevimeline in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e0c6355f-cb55-4eb3-b52f-b5fd08914ae4 GET /v1/drugs/e0c6355f-cb55-4eb3-b52f-b5fd08914ae4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "30",
"substance": "CEVIMELINE HYDROCHLORIDE",
"productndc": "72789-457",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA216682",
"marketing_category": "ANDA"
}See everything about cevimeline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.